Allelic effects on KLHL17 expression underlie a pancreatic cancer genome-wide association signal at chr1p36.33
Abstract
Abstract Pancreatic Ductal Adenocarcinoma (PDAC) is the third leading cause of cancer-related deaths in the U.S. Both rare and common germline variants contribute to PDAC risk. Here, we fine-map and functionally characterize a common PDAC risk signal at chr1p36.33 (tagged by rs13303010) identified through a genome wide association study (GWAS). One of the fine-mapped SNPs, rs13303160 (OR = 1.23 (95% CI 1.15-1.32), P-value = 2.74×10−9, LD r2 = 0.93 with rs13303010 in 1000 G EUR samples) demonstrated allele-preferential gene regulatory activity in vitro and binding of JunB and JunD in vitro and in vivo. Expression Quantitative Trait Locus (eQTL) analysis identified KLHL17 as a likely target gene underlying the signal. Proteomic analysis identified KLHL17 as a member of the Cullin-E3 ubiquitin ligase complex with vimentin and nestin as candidate substrates for degradation in PDAC-derived cells. In silico differential gene expression analysis of high and low KLHL17 expressing GTEx pancreas samples suggested an association between lower KLHL17 levels (risk associated) and pro-inflammatory pathways. We hypothesize that KLHL17 may mitigate cell injury and inflammation by recruiting nestin and vimentin for ubiquitination and degradation thereby influencing PDAC risk.
Article Details
Authors (79)
Katelyn E. Connelly
Katherine Hullin
Ehssan Abdolalizadeh
Jun Zhong
Institute of Functional Nano and Soft Materials Laboratory (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices
Daina Eiser
Aidan O’Brien
Irene Collins
Sudipto Das
Gerard Duncan
Demetrius Albanes
Gabriella Andreotti
Alan A. Arslan
Laura Beane-Freeman
Sonja I. Berndt
Julie E. Buring
Daniele Campa
Federico Canzian
Yu Chen
Charles C. Chung
A. Heather Eliassen
J. Michael Gaziano
Edward L. Giovannucci
Phyllis J. Goodman
Christopher A. Haiman
Belynda Hicks
Amy Hutchinson
Miranda R. Jones
Verena Katzke
Charles Kooperberg
Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Peter Kraft
I-Min Lee
Loic LeMarchand
Núria Malats
Michelle R. Manning
Satu Männistö
Roger Milne
Steven C. Moore
Lorelei Mucci
Alpa V. Patel
Population Science American Cancer Society Atlanta Georgia USA
Ulrike Peters
Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Francisco X. Real
Nathaniel Rothman
Howard D. Sesso
Veronica W. Setiawan
Xiao-Ou Shu
Debra Silverman
Meir J. Stampfer
Melissa C. Southey
Geoffrey S. Tobias
Thérèse Truong
Caroline Um
Kala Visvanathan
Nicolas Wentzensen
Division of Cancer Epidemiology and Genetics National Cancer Institute, National Institutes of Health Rockville Maryland USA
Emily White
Chen Yuan
Wei Zheng
Jean Wactawski-Wende
Walter C. Willett
Rachael Z. Stoltzenberg-Solomon
Samuel O. Antwi
Paige M. Bracci
Steven Gallinger
Michael Goggins
Department of Oncology, the Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine
Manal Hassan
Elizabeth A. Holly
Rayjean J. Hung
Donghui Li
Biohub, Redwood City, CA, USA.
Rachel E. Neale
Kari G. Rabe
Harvey A. Risch
Herbert Yu
Stephen J. Chanock
Rachael Z. Stolzenberg-Solomon
Alison P. Klein
Brian M. Wolpin
Jason W. Hoskins
Thorkell Andresson
Jill P. Smith
Laufey T. Amundadottir